Furthermore multiple GWAS studies have identified the CDKN2A locus, particularly the region encoding the long non-coding RNA ANRIL which negatively regulates p16INK4A, as a hotspot for cardiovascular disease, type 2 diabetes, and frailty. This evidence concerns the gene CDKN2A and type 2 diabetes mellitus.